Clinics and health networks
Development of preventive, pharmacogenetic and cardiometabolic panels integrated with medical care.
Multiplex develops genetic products —and soon epigenetic ones— for health organizations, ready to integrate into their operation or launch under their own brand.
Each segment has different needs. Multiplex adapts development, interpretation and integration to your context.
Development of preventive, pharmacogenetic and cardiometabolic panels integrated with medical care.
Fast addition of new molecular-diagnostics lines and white-label products.
Preventive and personalized-medicine programs, with responsible handling of sensitive data.
Value-added genetic services to support dispensing and adherence.
Genetic programs (and epigenetic ones in development) for nutrition, metabolic health and monitoring.
Custom panels and processing capacity for studies and cohorts.
API integration of results and reports into your own platforms and apps.
White-label genetic products —with epigenetics in development— to differentiate your offering.
Tell us your goal and estimated volume. We'll prepare a technical and commercial proposal.
We'll prepare a technical and commercial proposal based on your goal, volume and timeline.